Drug intelligence / Profile preview

Wannian Spring medicinal wine

Development stage: Preclinical
Lead developer: Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Administration: Oral

Overview

Wannian Spring medicinal wine is a Traditional Chinese Medicine (TCM) formulation developed by the Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine. It is an oral liquid preparation used primarily for the treatment of early-stage knee osteoarthritis. The formulation is designed to alleviate joint pain and reduce inflammation, often evaluated in combination with topical non-steroidal anti-inflammatory drugs (NSAIDs) like loxoprofen. Clinical evaluation focuses on its ability to improve clinical symptoms and modulate inflammatory markers in patients with degenerative joint disease.

Brand names: Wannian Spring medicinal wine
Other names: Wannianqing medicinal wineWannianqing Yaojiu

Beyond the preview

Go deeper on Wannian Spring medicinal wine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wannian Spring medicinal wine.

Explore the full profile